Publication | Closed Access

Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent mice

Immunocompetent MiceDisseminated Peritoneal TumorViral PathogenesisImmunologyPathologyVirologyTherapeutic VaccineImmunoeditingOncolytic Viral TherapyImmunotherapyMedicineViral OncologyCancer-associated Virus